BAINBRIDGE, Ga.--MHG, a leader in biopolymer manufacturing and specialty toll manufacturing services announced today their Board of Directors has approved a new Chief Executive Officer for the company. Stephen Croskrey will take over all duties of the role effective immediately.
“I am thrilled to join the MHG team,” stated Stephen Croskrey. “MHG provides a lot of great products worldwide and is a revolutionary company changing the plastics industry. I see tremendous potential for growth and I look forward to helping the company increase value, as well as work with the team on enhancing business development opportunities, expanding the range of products offered and increasing production capabilities.”
One of Croskrey’s first undertakings is the planned expansion of the PHA pilot biorefinery eightfold. PHA is one of the newest technologies offered by MHG and is also the world’s first bioplastic to be certified as degradable in marine water. By expanding, MHG expects to increase PHA sampling activity and ramp up the customer application approval process. Additionally, the company will commission an engineering study for the nation’s first commercial PHA biorefinery. MHG plans to begin the process of expanding this summer.
Croskrey is a proven leader with more than 20 years of experience in providing leadership for companies that manufacture and sell products including industrial fibers, medical devices and law enforcement gear. He previously served as the President and CEO of Armor Holding Products LLC, a major manufacturer of armor systems for the military, law enforcement and commercial markets.
During his 6-year tenure at Armor Holding Products LLC, Croskrey completed 13 acquisition transactions, which resulted in the annual revenue increasing from $45 million to over $300 million.
In addition to his vast work experience, Croskrey holds a Master’s in Business Administration from the Kellogg School of Management at Northwestern University and earned his Bachelor’s of Science in General Engineering at the United States Military Academy at West Point.
“The Board performed an extensive search and interviewing process to find the appropriate match for our company, and we feel Stephen Croskrey is the right fit,” stated Stuart Pratt, Chairman of the Board of Directors at MHG. “Stephen is a proven leader and an exceptional businessman with great insights into many of the different industries in which we work. His vision for the company is in line with the Board’s, and his leadership is exactly what MHG needs as we continue to grow the company.”
MHG recently announced the opening of a new division in the company, which will be dedicated solely to Specialty Toll Manufacturing. The opening of this division brings further visibility among major international customers that MHG can be a cost effective option due to their expertise, state of the art equipment, laboratories, logistic services and 70 million pounds of excess capacity.
For more information about MHG’s products and services, email us, call 229-243-7075, or visit MHGBio.com, where you will find comprehensive information about what we do. Also be sure to follow MHG on Facebook; Instagram; Linkedin; Twitter; YouTube; and Google+.
Meredian Holdings Group, Inc., also known as MHG, is the holding company of Meredian Inc., a recognized world leader in the development of polyhydroxyalkanoates (PHA) and DaniMer Scientific, L.L.C., a specialist in the customization of biopolymer formulations that combine PHA, PLA and other biopolymers through a proprietary reactive extrusion process. Supported by a world-class group of dedicated, highly skilled team members, MHG offers a comprehensive selection of biopolymers that support the company’s core values of utilizing sustainable and renewable bioplastics to improve people’s lives at work and home. MHG and its subsidiaries currently own more than 125 patents across nearly 20 countries. MHG is headquartered in Bainbridge, Ga.